Group One Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-902
| Closed | -$392 | – | 8255 |
|
|
2022
Q4 | $392 | Hold |
902
| – | – | ﹤0.01% | 6972 |
|
|
2022
Q3 | $0 | Sell |
902
-14
| -2% | -$5 | ﹤0.01% | 8539 |
|
|
2022
Q2 | $0 | Sell |
916
-2,048
| -69% | -$848 | ﹤0.01% | 8812 |
|
|
2022
Q1 | $2K | Sell |
2,964
-1,800
| -38% | -$1.53K | ﹤0.01% | 7780 |
|
|
2021
Q4 | $6K | Sell |
4,764
-50,977
| -91% | -$90.5K | ﹤0.01% | 7608 |
|
|
2021
Q3 | $121K | Sell |
55,741
-30,101
| -35% | -$65.5K | ﹤0.01% | 5723 |
|
|
2021
Q2 | $234K | Sell |
85,842
-29,108
| -25% | -$72.4K | ﹤0.01% | 5065 |
|
|
2021
Q1 | $300K | Buy |
+114,950
| New | +$325K | ﹤0.01% | 4578 |
|
|
2020
Q4 | – | Sell |
-8,035
| Closed | -$23.4K | – | 7187 |
|
|
2020
Q3 | $37K | Sell |
8,035
-2,242
| -22% | -$7.4K | ﹤0.01% | 4834 |
|
|
2020
Q2 | $29K | Buy |
10,277
+304
| +3% | +$975 | ﹤0.01% | 4670 |
|
|
2020
Q1 | $24K | Sell |
9,973
-66,966
| -87% | -$242K | ﹤0.01% | 4146 |
|
|
2019
Q4 | $394K | Buy |
76,939
+37,329
| +94% | +$207K | ﹤0.01% | 2636 |
|
|
2019
Q3 | $256K | Buy |
+39,610
| New | +$273K | ﹤0.01% | 2909 |
|
|
2019
Q2 | – | Sell |
-4,364
| Closed | -$33.2K | – | 5550 |
|
|
2019
Q1 | $46K | Buy |
4,364
+932
| +27% | +$9.28K | ﹤0.01% | 3612 |
|
|
2018
Q4 | $27K | Buy |
+3,432
| New | +$49.5K | ﹤0.01% | 3891 |
|
|
2018
Q3 | – | Sell |
-15,893
| Closed | -$289K | – | 5750 |
|
|
2018
Q2 | $287K | Sell |
15,893
-16,950
| -52% | -$250K | ﹤0.01% | 2755 |
|
|
2018
Q1 | $349K | Buy |
32,843
+26,482
| +416% | +$425K | ﹤0.01% | 2340 |
|
|
2017
Q4 | $268K | Sell |
6,361
-31,246
| -83% | -$1.4M | ﹤0.01% | 2732 |
|
|
2017
Q3 | $2.07M | Buy |
37,607
+31,152
| +483% | +$5.26M | 0.02% | 1023 |
|
|
2017
Q2 | $1.2M | Buy |
6,455
+47
| +0.7% | +$8.24K | 0.01% | 1314 |
|
|
2017
Q1 | $766K | Buy |
6,408
+2,937
| +85% | +$308K | 0.01% | 1534 |
|
|
2016
Q4 | $345K | Buy |
3,471
+772
| +29% | +$81.3K | ﹤0.01% | 2028 |
|
|
2016
Q3 | $302K | Buy |
+2,699
| New | +$324K | ﹤0.01% | 2183 |
|
|
2016
Q2 | – | Sell |
-1,039
| Closed | -$104K | – | 5034 |
|
|
2016
Q1 | $95K | Buy |
1,039
+479
| +86% | +$51.1K | ﹤0.01% | 2865 |
|
|
2015
Q4 | $81K | Buy |
+560
| New | +$72.9K | ﹤0.01% | 3120 |
|
Other funds holding SIOX
JC
CIA
BBA
Group One Trading's SIOX Position: Q1 2023 in Review
Group One Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 902 shares — an estimated $392 sold.
Group One Trading first reported a position in SIOX in Q4 2015 and held it in 25 quarters. The position peaked at $2.07M in Q3 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.
- Group One Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 902 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $392.
- Group One Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 25 quarters.
- Group One Trading's Sio Gene Therapies Inc. Common Stock position peaked at $2.07M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.